Search Thermo Fisher Scientific
- Contáctenos
- Orden Rápida
-
¿No tiene una cuenta? Crear una cuenta
Search Thermo Fisher Scientific
Because RSV, influenza, and COVID-19 share symptoms, accurate testing is needed to distinguish one from the other. This CE-IVD marked multiplex PCR test is specifically designed to detect and differentiate between multiple respiratory viruses as the ongoing COVID-19 pandemic overlaps with respiratory virus season. The test uses an assay design with two SARS-CoV-2 targets to compensate for emerging variants and mutations and help provide confidence in results.
Features of the TaqPath COVID-19, flu A/B, RSV combo kit |
Targets |
|
---|---|
Internal control |
|
Authorized sample types |
|
Recommended sample preparation | |
Authorized instruments | |
Limit of detection (LOD) |
|
The Applied Biosystems Pathogen Interpretive Software CE-IVD Edition is part of the required workflow.
You may download the software upon kit purchase. Labs following the certified workflow are required to complete an eLearning course and pass an exam to download.
Follow the instructions below to obtain the software from your local support team:
Product | Included component | Qty | Cat. No. |
---|---|---|---|
TaqPath COVID-19, Flu A/B, RSV Combo Kit | TaqPath COVID-19, Flu A/B, RSV RT-PCR Assay (1 tube) | 1,000 rxns | |
MS2 Phage Control (10 tubes) | |||
TaqPath COVID-19, Flu A/B, RSV Control Kit (1 box with 10 tubes) | |||
TaqPath COVID-19 Control Dilution Buffer (1 box with 10 tubes) | |||
TaqPath 1-Step Multiplex Master Mix, No ROX (1 bottle with 10 mL) |
Find the approved Instructions for Use (IFU) for your country. (Note: Product availability varies by country.)